Shopping Cart
- Remove All
- Your shopping cart is currently empty
Gentulizumab (Gensci-059) is a humanized IgG4 antibody that targets and binds to CD47. It demonstrates strong binding affinity to CD47 in both humans and monkeys and effectively inhibits the interaction between CD47 and SIRPα. Gentulizumab exhibits potent antitumor activity. For isotype control, refer to HumanIgG4(S228P) kappa, Isotype Control.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Gentulizumab (Gensci-059) is a humanized IgG4 antibody that targets and binds to CD47. It demonstrates strong binding affinity to CD47 in both humans and monkeys and effectively inhibits the interaction between CD47 and SIRPα. Gentulizumab exhibits potent antitumor activity. For isotype control, refer to HumanIgG4(S228P) kappa, Isotype Control. |
Alias | Gentulizumab, Gensci-059 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.